100 Recruiting Studies Using Cyclophosphamide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cyclophosphamide
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
📍 The University of Arizona Cancer Center - North Campus /ID# 242219 — Tucson, Arizona
Non-Hodgkin Lymphoma
View Study & Checklist ➔Delayed Tolerance Through Mixed Chimerism
📍 Massachusetts General Hospital — Boston, Massachusetts
Kidney Failure
View Study & Checklist ➔S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
📍 Regional Medical Center — Anniston, Alabama
Breast Cancer
View Study & Checklist ➔Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Itacitinib for the Prevention of Graft Versus Host Disease
📍 M D Anderson Cancer Center — Houston, Texas
Hematologic and Lymphocytic Disorder
View Study & Checklist ➔A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
Solid Tumor
View Study & Checklist ➔Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
📍 University of Florida Proton Therapy Institute — Jacksonville, Florida
Rhabdomyosarcoma
View Study & Checklist ➔Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Sickle Cell Disease
View Study & Checklist ➔Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
📍 MorphoSys Research Site — Daphne, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation
📍 City of Hope Medical Center — Duarte, California
Recurrent Transformed Chronic Lymphocytic Leukemia
View Study & Checklist ➔Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
📍 Roswell Park Cancer Institute — Buffalo, New York
Advanced Fallopian Tube Carcinoma
View Study & Checklist ➔Evolutionary Therapy for Rhabdomyosarcoma
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Rhabdomyosarcoma
View Study & Checklist ➔Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Pancreatic Cancer
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
📍 University of Arizona Cancer Center - North Campus /ID# 227463 — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Stage II Childhood Hodgkin Lymphoma
View Study & Checklist ➔GFRα4 CAR T Cells in MTC Patients
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Metastatic Medullary Thyroid Cancer
View Study & Checklist ➔Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)
📍 MD Anderson Cancer Center — Houston, Texas
Colorectal Cancer
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease
View Study & Checklist ➔Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
📍 Research Site — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
📍 Local Institution - 0011 — Birmingham, Alabama
Multiple Sclerosis
View Study & Checklist ➔A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
📍 Local Institution - 0131 — Los Angeles, California
Multiple Myeloma
View Study & Checklist ➔Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
📍 Froedtert Hospital & Medical College of Wisconsin — Milwaukee, Wisconsin
Invasive Breast Cancer
View Study & Checklist ➔Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
📍 City of Hope Medical Center — Duarte, California
Allogeneic Hematopoietic Stem Cell Transplant Recipient
View Study & Checklist ➔Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Multiple Myeloma
View Study & Checklist ➔A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Multiple Myeloma
View Study & Checklist ➔TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
📍 Moffitt Cancer Center — Tampa, Florida
Squamous Cell Carcinoma of Head and Neck
View Study & Checklist ➔A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
📍 James P. Wilmot Cancer Institute, University of Rochester Medical Center — Rochester, New York
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma
📍 Houston Methodist Hospital — Houston, Texas
Sarcoma
View Study & Checklist ➔Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
📍 Cleveland Clinic — Cleveland, Ohio
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101
📍 Hospital of the Universithy of Pennsylvania — Philadelphia, Pennsylvania
Idiopathic Inflammatory Myopathies
View Study & Checklist ➔Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Lymphoma
View Study & Checklist ➔Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
📍 Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina
Epithelial Ovarian Cancer
View Study & Checklist ➔Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors
📍 University of Alabama at Birmingham/Children's of Alabama — Birmingham, Alabama
Ewing Sarcoma
View Study & Checklist ➔A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
📍 MD Anderson Cancer Center — Houston, Texas
Advanced Solid Tumor
View Study & Checklist ➔Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
SCID
View Study & Checklist ➔Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Locally Advanced Melanoma
View Study & Checklist ➔Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
📍 University of Colorado — Aurora, Colorado
Hematologic Diseases
View Study & Checklist ➔Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
Malignant Pleural Mesothelioma (MPM)
View Study & Checklist ➔Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
Pancreatic Cancer
View Study & Checklist ➔Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
📍 Research Site — Springdale, Arkansas
Breast Neoplasms
View Study & Checklist ➔Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
View Study & Checklist ➔A Study of N9 Chemotherapy in Children With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Neuroblastoma
View Study & Checklist ➔Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Prostate Cancer
View Study & Checklist ➔A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Acute Myeloid Leukemia (AML)
View Study & Checklist ➔'ADVANCE' (A Pilot Trial)
📍 City of Hope National Medical Center — Duarte, California
Breast Cancer
View Study & Checklist ➔Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
📍 M D Anderson Cancer Center — Houston, Texas
Advanced Malignant Solid Neoplasm
View Study & Checklist ➔A Phase 1/2 Trial of ADI-270 in ccRCC
📍 Adicet Clinical Trials — Redwood City, California
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
📍 City of Hope National Medical Center — Duarte, California
Neoplasms
View Study & Checklist ➔Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ganglioneuroblastoma
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist ➔Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
📍 Northeast Alabama Regional Medical Center — Anniston, Alabama
Breast Adenocarcinoma
View Study & Checklist ➔A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL
📍 Beth Isreal Deaconess Medical Center — Boston, Massachusetts
Chronic Lymphocytic Leukemia
View Study & Checklist ➔ATG Plus PTCy vs ATG for CGVHD Prophylaxis
📍 Kinghorn Cancer Centre, St Vincent's Health Network — Darlinghurst, New South Wales
Acute Leukemia
View Study & Checklist ➔Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
DOCK8 Deficiency
View Study & Checklist ➔A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
📍 Local Institution - 0106 — Phoenix, Arizona
Lupus Erythematosus, Systemic
View Study & Checklist ➔Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
📍 City of Hope — Duarte, California
CLL/SLL
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
📍 University of Illinois — Chicago, Illinois
Triple Negative Breast Cancer
View Study & Checklist ➔A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Alveolar Rhabdomyosarcoma
View Study & Checklist ➔Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
📍 Princess Margaret Cancer Centre — Toronto, Ontario
NY-ESO-1 Expressing Solid Tumors in HLA-A2 Positive Patients
View Study & Checklist ➔Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Primary Myelofibrosis
View Study & Checklist ➔High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Chronic Granulomatous Disease Transplant
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
📍 Local Institution - 0152 — Birmingham, Alabama
Lymphoma, Follicular
View Study & Checklist ➔Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Hematopoietic and Lymphoid Cell Neoplasm
View Study & Checklist ➔FT819 in Subjects With B-cell Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
Lymphoma, B-Cell
View Study & Checklist ➔Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Myeloma
View Study & Checklist ➔In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Acute Lymphocytic Leukemia
View Study & Checklist ➔Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
📍 City of Hope National Medical Center — Duarte, California
Neoplasms
View Study & Checklist ➔Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
📍 Research Site — Daphne, Alabama
Breast Cancer
View Study & Checklist ➔Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey
Ann Arbor Stage III Non-Hodgkin Lymphoma
View Study & Checklist ➔Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma
📍 University of California, San Francisco — San Francisco, California
Refractory Multiple Myeloma
View Study & Checklist ➔Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
📍 University of Rochester — Rochester, New York
DLBCL
View Study & Checklist ➔A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Recurrent B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
Melanoma
View Study & Checklist ➔CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Prostate Cancer
View Study & Checklist ➔Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
📍 M D Anderson Cancer Center — Houston, Texas
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
📍 Laura and Isaac Perlmutter Cancer Center at NYU Langone — New York, New York
Locally Advanced Unresectable Breast Carcinoma
View Study & Checklist ➔Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
Recurrent Fallopian Tube Carcinoma
View Study & Checklist ➔Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
📍 NYU Langone Health — New York, New York
Graft Vs Host Disease
View Study & Checklist ➔